Chongqing Huasen Pharmaceutical Co., Ltd. announces abnormal stock trading fluctuations. The stock price has risen significantly over three consecutive trading days, exceeding the 20% threshold. The company confirms no undisclosed material events and that its operations are stable. Investors are cautioned about market risks due to high P/E and P/B ratios compared to the industry average.
Summary generated by AI · Always verify with source document
Securities Code: 002907
Securities Abbreviation: Huasen Pharmaceutical
Announcement Number: 2026-056
Chongqing Huasen Pharmaceutical Co., Ltd.
Announcement on Abnormal Stock Trading Fluctuations
The company and the board of directors of the company guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.